MarketLens

Did MannKind's Q1 2026 Earnings Report Signal a Turning Point

3 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Did FinVolution's Q1 2026 Results Signal a Turning Point

2 months ago

Did Bilibili's Q1 2026 Earnings Mark a Turning Point

2 months ago

Did Boston Properties' Q1 2026 Earnings Signal a Turning Point for Office REITs

3 months ago

Did Marvell Technology's Q4 Earnings Signal a Turning Point for Investors

5 months ago

MannKind (NASDAQ:MNKD) Shares Gap Up – Still a Buy?

MannKind (MNKD) shares gapped up ~4.4% to open at $4.06 from a $3.89 prior close, after key news stories this week.

MNKD

Stock News•1 months ago

Why This MannKind Insider Stock Sale Matters Less Than a 9% Royalty at Risk

MannKind insider sold 65,808 shares (~$269K), representing 6% of direct holdings. The sale is overshadowed by a 9% royalty stream at risk.

MNKD

Stock News•1 months ago

MannKind Awarded Breakthrough T1D Grant to Support Advancement of INHALE-1ST Pediatric Trial of Afrezza® in Youth with Newly-Diagnosed T1D

MannKind received a Breakthrough T1D grant to advance its INHALE-1ST pediatric trial of Afrezza in youth with newly-diagnosed type 1 diabetes, underscoring interest in inhaled insulin.

MNKD

Stock News•3 months ago

MannKind Corporation (MNKD) Q1 2026 Earnings Call Transcript

MannKind Corporation (MNKD) released its Q1 2026 earnings transcript, detailing the company's financial performance and operational progress for the period. The report provides updated insights into r...

MNKD